Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fanconi Anemia | 112 | 2022 | 319 | 18.730 |
Why?
|
DNA Repair | 91 | 2023 | 2046 | 9.440 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 57 | 2021 | 148 | 5.200 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 38 | 2021 | 100 | 5.150 |
Why?
|
DNA Replication | 30 | 2023 | 1399 | 4.250 |
Why?
|
DNA Damage | 73 | 2022 | 2432 | 4.210 |
Why?
|
BRCA1 Protein | 33 | 2023 | 1149 | 3.950 |
Why?
|
Cell Cycle Proteins | 41 | 2023 | 3462 | 3.830 |
Why?
|
DNA Breaks, Double-Stranded | 17 | 2023 | 594 | 3.690 |
Why?
|
Nuclear Proteins | 64 | 2021 | 5853 | 3.570 |
Why?
|
Endopeptidases | 19 | 2016 | 772 | 2.920 |
Why?
|
DNA-Binding Proteins | 66 | 2023 | 9648 | 2.890 |
Why?
|
Receptors, Erythropoietin | 45 | 2001 | 147 | 2.310 |
Why?
|
Ovarian Neoplasms | 31 | 2023 | 4838 | 2.240 |
Why?
|
Ubiquitin | 30 | 2014 | 852 | 2.220 |
Why?
|
DNA-Directed DNA Polymerase | 11 | 2023 | 486 | 2.190 |
Why?
|
Erythropoietin | 35 | 2001 | 726 | 1.810 |
Why?
|
Genomic Instability | 20 | 2021 | 695 | 1.790 |
Why?
|
Proliferating Cell Nuclear Antigen | 13 | 2019 | 285 | 1.630 |
Why?
|
BRCA2 Protein | 16 | 2022 | 794 | 1.550 |
Why?
|
HeLa Cells | 33 | 2021 | 3128 | 1.470 |
Why?
|
Fanconi Anemia Complementation Group A Protein | 15 | 2020 | 46 | 1.380 |
Why?
|
Genes, BRCA1 | 12 | 2022 | 781 | 1.370 |
Why?
|
Hematopoietic Stem Cells | 19 | 2021 | 3386 | 1.290 |
Why?
|
DNA Helicases | 11 | 2021 | 859 | 1.280 |
Why?
|
DNA | 30 | 2023 | 7301 | 1.270 |
Why?
|
Mitomycin | 24 | 2010 | 259 | 1.260 |
Why?
|
Genes, BRCA2 | 10 | 2022 | 618 | 1.220 |
Why?
|
Drug Resistance, Neoplasm | 18 | 2021 | 5172 | 1.220 |
Why?
|
Signal Transduction | 55 | 2021 | 23403 | 1.220 |
Why?
|
Ubiquitins | 11 | 2016 | 384 | 1.190 |
Why?
|
Cell Cycle | 19 | 2016 | 2967 | 1.190 |
Why?
|
Cystadenocarcinoma, Serous | 6 | 2022 | 450 | 1.170 |
Why?
|
Pyrazines | 10 | 2021 | 1230 | 1.140 |
Why?
|
Ubiquitination | 17 | 2021 | 1012 | 1.140 |
Why?
|
Proteins | 28 | 2012 | 6103 | 1.130 |
Why?
|
Neoplasms | 26 | 2023 | 21683 | 1.110 |
Why?
|
Cisplatin | 14 | 2020 | 1662 | 0.990 |
Why?
|
Protein Binding | 34 | 2021 | 9386 | 0.940 |
Why?
|
Fanconi Anemia Complementation Group C Protein | 14 | 2018 | 21 | 0.930 |
Why?
|
Bone Marrow | 9 | 2021 | 2948 | 0.910 |
Why?
|
Cell Line | 70 | 2020 | 15997 | 0.910 |
Why?
|
Phosphoproteins | 6 | 2022 | 2440 | 0.910 |
Why?
|
Cell Nucleus | 16 | 2023 | 2969 | 0.900 |
Why?
|
Fanconi Anemia Complementation Group G Protein | 12 | 2018 | 18 | 0.880 |
Why?
|
Ataxia Telangiectasia | 2 | 2020 | 112 | 0.870 |
Why?
|
Multienzyme Complexes | 5 | 2011 | 686 | 0.870 |
Why?
|
Animals | 145 | 2022 | 168757 | 0.860 |
Why?
|
Mutation | 48 | 2022 | 29786 | 0.860 |
Why?
|
Recombination, Genetic | 12 | 2021 | 1586 | 0.860 |
Why?
|
Ubiquitin Thiolesterase | 6 | 2016 | 449 | 0.860 |
Why?
|
Exodeoxyribonucleases | 5 | 2021 | 180 | 0.840 |
Why?
|
Multiprotein Complexes | 7 | 2021 | 1119 | 0.820 |
Why?
|
Immediate-Early Proteins | 7 | 2001 | 453 | 0.810 |
Why?
|
Pyrazoles | 6 | 2021 | 1972 | 0.800 |
Why?
|
Protein Processing, Post-Translational | 15 | 2020 | 1990 | 0.800 |
Why?
|
Chromatin | 14 | 2021 | 2934 | 0.800 |
Why?
|
Genetic Complementation Test | 18 | 2016 | 562 | 0.800 |
Why?
|
Ubiquitin-Protein Ligases | 10 | 2020 | 1861 | 0.790 |
Why?
|
Interleukin-3 | 15 | 2003 | 444 | 0.770 |
Why?
|
Arabidopsis Proteins | 11 | 2013 | 262 | 0.760 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.760 |
Why?
|
Metabolic Networks and Pathways | 3 | 2017 | 783 | 0.750 |
Why?
|
Humans | 281 | 2023 | 744343 | 0.740 |
Why?
|
Chromatin Assembly and Disassembly | 3 | 2014 | 635 | 0.730 |
Why?
|
N-Glycosyl Hydrolases | 1 | 2020 | 68 | 0.720 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2022 | 736 | 0.720 |
Why?
|
Tumor Suppressor Protein p53 | 7 | 2022 | 2948 | 0.710 |
Why?
|
S Phase | 12 | 2016 | 423 | 0.700 |
Why?
|
DNA Repair-Deficiency Disorders | 2 | 2018 | 29 | 0.700 |
Why?
|
Cross-Linking Reagents | 11 | 2016 | 694 | 0.690 |
Why?
|
Mice | 94 | 2022 | 81183 | 0.690 |
Why?
|
Phthalazines | 8 | 2023 | 363 | 0.670 |
Why?
|
Cell Line, Tumor | 37 | 2021 | 16689 | 0.660 |
Why?
|
Viral Envelope Proteins | 12 | 2000 | 635 | 0.640 |
Why?
|
Gene Expression Regulation | 19 | 2012 | 12072 | 0.630 |
Why?
|
Transfection | 36 | 2016 | 5892 | 0.620 |
Why?
|
Receptors, Cell Surface | 19 | 1992 | 2866 | 0.610 |
Why?
|
Endonucleases | 3 | 2019 | 380 | 0.600 |
Why?
|
Embryo Loss | 2 | 2015 | 59 | 0.590 |
Why?
|
Carcinoma, Squamous Cell | 8 | 2021 | 4034 | 0.590 |
Why?
|
Trans-Activators | 10 | 2021 | 2924 | 0.590 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 14 | 2023 | 11524 | 0.590 |
Why?
|
Anus Neoplasms | 2 | 2021 | 332 | 0.580 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2015 | 484 | 0.580 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2020 | 644 | 0.570 |
Why?
|
Gene Expression Regulation, Neoplastic | 19 | 2021 | 8428 | 0.570 |
Why?
|
Transforming Growth Factor beta | 4 | 2022 | 2007 | 0.560 |
Why?
|
Hematopoiesis | 7 | 2020 | 2072 | 0.560 |
Why?
|
Friend murine leukemia virus | 6 | 2000 | 65 | 0.550 |
Why?
|
Aldehydes | 1 | 2017 | 167 | 0.550 |
Why?
|
DNA Repair Enzymes | 3 | 2021 | 349 | 0.550 |
Why?
|
Carrier Proteins | 8 | 2020 | 5021 | 0.550 |
Why?
|
Chromosomal Instability | 7 | 2016 | 184 | 0.550 |
Why?
|
Protein Kinases | 5 | 2012 | 1640 | 0.550 |
Why?
|
Cell Survival | 13 | 2020 | 5882 | 0.540 |
Why?
|
Organoids | 2 | 2019 | 701 | 0.540 |
Why?
|
Cell Line, Transformed | 15 | 2007 | 898 | 0.540 |
Why?
|
Rad51 Recombinase | 8 | 2015 | 189 | 0.540 |
Why?
|
Amino Acid Sequence | 36 | 2020 | 13815 | 0.530 |
Why?
|
Poly(ADP-ribose) Polymerases | 7 | 2020 | 440 | 0.520 |
Why?
|
Protein-Tyrosine Kinases | 17 | 2020 | 2455 | 0.510 |
Why?
|
Ultraviolet Rays | 15 | 2019 | 1060 | 0.500 |
Why?
|
Cloning, Molecular | 20 | 2012 | 4320 | 0.500 |
Why?
|
Fanconi Anemia Complementation Group E Protein | 4 | 2014 | 4 | 0.500 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2020 | 2916 | 0.490 |
Why?
|
Antineoplastic Agents | 15 | 2023 | 13695 | 0.490 |
Why?
|
Phosphorylation | 26 | 2020 | 8436 | 0.490 |
Why?
|
Molecular Sequence Data | 43 | 2014 | 18111 | 0.470 |
Why?
|
Germ-Line Mutation | 7 | 2020 | 1788 | 0.460 |
Why?
|
Novobiocin | 2 | 2023 | 35 | 0.450 |
Why?
|
DNA, Neoplasm | 2 | 2018 | 1758 | 0.450 |
Why?
|
Nucleotidyltransferases | 2 | 2012 | 220 | 0.450 |
Why?
|
HEK293 Cells | 9 | 2020 | 4204 | 0.440 |
Why?
|
Chickens | 6 | 2014 | 865 | 0.440 |
Why?
|
Proto-Oncogene Proteins | 13 | 2009 | 4554 | 0.430 |
Why?
|
Lymphocytes | 10 | 2009 | 2617 | 0.430 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2016 | 890 | 0.420 |
Why?
|
RNA, Small Interfering | 15 | 2021 | 3505 | 0.420 |
Why?
|
Gene Expression Regulation, Enzymologic | 4 | 2010 | 1213 | 0.420 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 3 | 2018 | 105 | 0.410 |
Why?
|
Killer Cells, Natural | 10 | 2000 | 2133 | 0.410 |
Why?
|
Adenosine Triphosphatases | 4 | 2023 | 839 | 0.410 |
Why?
|
Spleen Focus-Forming Viruses | 5 | 1994 | 16 | 0.400 |
Why?
|
Radiation, Ionizing | 5 | 2013 | 258 | 0.400 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5256 | 0.390 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2013 | 2942 | 0.390 |
Why?
|
Small Ubiquitin-Related Modifier Proteins | 1 | 2011 | 72 | 0.390 |
Why?
|
Microsatellite Instability | 4 | 2019 | 684 | 0.390 |
Why?
|
Receptors, Immunologic | 6 | 1998 | 1423 | 0.390 |
Why?
|
Mutagens | 5 | 2016 | 168 | 0.380 |
Why?
|
Leukemia, Erythroblastic, Acute | 8 | 2000 | 189 | 0.370 |
Why?
|
Bloom Syndrome | 2 | 2009 | 8 | 0.370 |
Why?
|
Cell Division | 21 | 2003 | 4568 | 0.360 |
Why?
|
Breast Neoplasms | 13 | 2020 | 20822 | 0.360 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2915 | 0.360 |
Why?
|
Fibroblasts | 15 | 2020 | 4161 | 0.360 |
Why?
|
Fanconi Anemia Complementation Group L Protein | 4 | 2014 | 5 | 0.360 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2023 | 9239 | 0.360 |
Why?
|
Gene Deletion | 5 | 2013 | 2751 | 0.350 |
Why?
|
Fanconi Anemia Complementation Group F Protein | 7 | 2007 | 8 | 0.350 |
Why?
|
Histones | 2 | 2017 | 2599 | 0.350 |
Why?
|
Deoxycytidine | 4 | 2023 | 826 | 0.350 |
Why?
|
Enzyme Inhibitors | 7 | 2015 | 3798 | 0.340 |
Why?
|
Chromosome Breakage | 9 | 2016 | 173 | 0.340 |
Why?
|
Gene Knockdown Techniques | 7 | 2018 | 1655 | 0.340 |
Why?
|
Cytokinesis | 1 | 2010 | 177 | 0.340 |
Why?
|
Cells, Cultured | 25 | 2020 | 19229 | 0.340 |
Why?
|
RNA-Binding Proteins | 7 | 2017 | 1903 | 0.330 |
Why?
|
DNA, Complementary | 10 | 2005 | 2050 | 0.330 |
Why?
|
Bone Marrow Cells | 4 | 2010 | 2513 | 0.330 |
Why?
|
Curcumin | 2 | 2007 | 96 | 0.320 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2021 | 3557 | 0.320 |
Why?
|
Genes, Tumor Suppressor | 1 | 2013 | 1097 | 0.320 |
Why?
|
Protein Kinase Inhibitors | 8 | 2023 | 5535 | 0.320 |
Why?
|
Zinc Fingers | 2 | 2010 | 585 | 0.310 |
Why?
|
CDC2 Protein Kinase | 3 | 2011 | 220 | 0.310 |
Why?
|
Piperazines | 5 | 2022 | 2488 | 0.310 |
Why?
|
Glutathione Transferase | 3 | 2010 | 595 | 0.310 |
Why?
|
Models, Biological | 13 | 2012 | 9583 | 0.310 |
Why?
|
RNA Interference | 8 | 2019 | 2889 | 0.310 |
Why?
|
Tumor Suppressor Proteins | 7 | 2013 | 2849 | 0.310 |
Why?
|
Carcinoma, Papillary | 1 | 2013 | 783 | 0.300 |
Why?
|
Milk Proteins | 5 | 2001 | 169 | 0.300 |
Why?
|
Radiation Tolerance | 5 | 2019 | 486 | 0.300 |
Why?
|
Transcription Factors | 11 | 2021 | 12208 | 0.300 |
Why?
|
Point Mutation | 6 | 2015 | 1623 | 0.300 |
Why?
|
Adenocarcinoma | 2 | 2023 | 6364 | 0.300 |
Why?
|
Transcriptional Activation | 2 | 2013 | 1783 | 0.300 |
Why?
|
Head and Neck Neoplasms | 2 | 2019 | 2734 | 0.290 |
Why?
|
Female | 74 | 2023 | 380194 | 0.290 |
Why?
|
Erythropoiesis | 8 | 2002 | 705 | 0.290 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2018 | 2020 | 0.280 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2009 | 627 | 0.280 |
Why?
|
Interleukin-2 | 11 | 2001 | 1904 | 0.280 |
Why?
|
Mitosis | 6 | 2021 | 1208 | 0.270 |
Why?
|
Base Sequence | 26 | 2018 | 12797 | 0.270 |
Why?
|
Microsatellite Repeats | 2 | 2019 | 802 | 0.270 |
Why?
|
Proteasome Endopeptidase Complex | 7 | 2015 | 1338 | 0.270 |
Why?
|
Mutation, Missense | 6 | 2018 | 2564 | 0.260 |
Why?
|
Growth Inhibitors | 2 | 1997 | 385 | 0.260 |
Why?
|
Mice, Knockout | 10 | 2021 | 14557 | 0.260 |
Why?
|
Protease Inhibitors | 3 | 2016 | 791 | 0.260 |
Why?
|
Models, Genetic | 7 | 2019 | 3494 | 0.260 |
Why?
|
G2 Phase | 4 | 2002 | 139 | 0.260 |
Why?
|
Enhancer Elements, Genetic | 4 | 2001 | 1341 | 0.250 |
Why?
|
Mice, Nude | 6 | 2018 | 3689 | 0.250 |
Why?
|
Interleukins | 7 | 1994 | 791 | 0.250 |
Why?
|
HLA-B Antigens | 3 | 1997 | 353 | 0.250 |
Why?
|
Leukocytes, Mononuclear | 5 | 2000 | 1836 | 0.250 |
Why?
|
Multigene Family | 6 | 2000 | 1102 | 0.250 |
Why?
|
Erythroid Precursor Cells | 4 | 1994 | 218 | 0.240 |
Why?
|
Apoptosis | 7 | 2021 | 9727 | 0.240 |
Why?
|
Endodeoxyribonucleases | 4 | 2018 | 165 | 0.240 |
Why?
|
Drug Resistance | 5 | 2018 | 1609 | 0.240 |
Why?
|
Rosaniline Dyes | 1 | 2023 | 51 | 0.240 |
Why?
|
Cell Proliferation | 6 | 2021 | 10481 | 0.240 |
Why?
|
Xenopus | 2 | 2020 | 712 | 0.240 |
Why?
|
Cell Death | 5 | 2019 | 1706 | 0.240 |
Why?
|
Phenotype | 16 | 2016 | 16365 | 0.230 |
Why?
|
Binding Sites | 7 | 2018 | 6114 | 0.230 |
Why?
|
DNA-Activated Protein Kinase | 2 | 2022 | 117 | 0.230 |
Why?
|
Protein Structure, Tertiary | 7 | 2014 | 3846 | 0.220 |
Why?
|
Bone Marrow Diseases | 2 | 2002 | 231 | 0.220 |
Why?
|
Tumor Cells, Cultured | 8 | 2021 | 6314 | 0.220 |
Why?
|
Receptors, Interleukin-3 | 4 | 1997 | 30 | 0.220 |
Why?
|
Echocardiography, Stress | 1 | 2003 | 131 | 0.220 |
Why?
|
Repressor Proteins | 1 | 2014 | 3023 | 0.220 |
Why?
|
Models, Molecular | 8 | 2020 | 5456 | 0.210 |
Why?
|
Transposases | 1 | 2022 | 107 | 0.210 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2023 | 1634 | 0.210 |
Why?
|
Genes, Immediate-Early | 3 | 1997 | 101 | 0.210 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 2021 | 3523 | 0.210 |
Why?
|
Receptors, Interleukin-2 | 6 | 2000 | 573 | 0.210 |
Why?
|
Blotting, Western | 7 | 2016 | 5179 | 0.200 |
Why?
|
Gene Silencing | 7 | 2017 | 1538 | 0.200 |
Why?
|
Glioblastoma | 3 | 2011 | 3481 | 0.200 |
Why?
|
Interleukin-12 | 7 | 1995 | 579 | 0.200 |
Why?
|
Genetic Predisposition to Disease | 8 | 2020 | 17446 | 0.200 |
Why?
|
Colony-Forming Units Assay | 1 | 2021 | 356 | 0.200 |
Why?
|
Mutagenesis | 5 | 2011 | 1266 | 0.200 |
Why?
|
Homozygote | 5 | 2013 | 1785 | 0.200 |
Why?
|
G1 Phase | 4 | 2014 | 415 | 0.190 |
Why?
|
Down-Regulation | 4 | 2016 | 3002 | 0.190 |
Why?
|
Protein Biosynthesis | 3 | 1999 | 2126 | 0.190 |
Why?
|
Neoplasm Proteins | 6 | 2018 | 3703 | 0.190 |
Why?
|
Pyridazines | 1 | 2022 | 202 | 0.190 |
Why?
|
Ficusin | 1 | 2020 | 15 | 0.190 |
Why?
|
Nucleic Acid Synthesis Inhibitors | 3 | 2014 | 112 | 0.190 |
Why?
|
RecQ Helicases | 2 | 2010 | 54 | 0.180 |
Why?
|
HSP90 Heat-Shock Proteins | 3 | 2021 | 434 | 0.180 |
Why?
|
Sequence Homology, Amino Acid | 7 | 2012 | 2839 | 0.180 |
Why?
|
T-Lymphocytes | 9 | 2001 | 10180 | 0.180 |
Why?
|
Recombinant Proteins | 16 | 2018 | 6622 | 0.180 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 1038 | 0.180 |
Why?
|
Leukemia, Experimental | 5 | 1997 | 246 | 0.180 |
Why?
|
Lysophospholipids | 1 | 2022 | 331 | 0.180 |
Why?
|
RNA, Messenger | 20 | 2017 | 13033 | 0.180 |
Why?
|
Heterozygote | 4 | 2017 | 2804 | 0.180 |
Why?
|
Retroviridae | 5 | 2006 | 914 | 0.180 |
Why?
|
Brain Neoplasms | 3 | 2011 | 8863 | 0.180 |
Why?
|
Polycythemia Vera | 3 | 2005 | 164 | 0.170 |
Why?
|
Biomarkers, Pharmacological | 1 | 2020 | 162 | 0.170 |
Why?
|
Flap Endonucleases | 1 | 2019 | 19 | 0.170 |
Why?
|
Alleles | 9 | 2016 | 6933 | 0.170 |
Why?
|
Telomere-Binding Proteins | 1 | 2020 | 116 | 0.170 |
Why?
|
Immunoblotting | 6 | 2011 | 1682 | 0.170 |
Why?
|
Cell Transformation, Viral | 3 | 2001 | 565 | 0.170 |
Why?
|
Leiomyosarcoma | 1 | 2023 | 477 | 0.170 |
Why?
|
Cytoplasmic Dyneins | 1 | 2018 | 25 | 0.170 |
Why?
|
Nucleic Acid Denaturation | 1 | 2018 | 111 | 0.170 |
Why?
|
DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2019 | 71 | 0.160 |
Why?
|
Genes, Neoplasm | 2 | 2017 | 376 | 0.160 |
Why?
|
Mice, Inbred C57BL | 9 | 2021 | 21827 | 0.160 |
Why?
|
Interferon Type I | 1 | 2022 | 542 | 0.160 |
Why?
|
Sequence Deletion | 6 | 2012 | 1526 | 0.160 |
Why?
|
Genes, Lethal | 1 | 2019 | 242 | 0.160 |
Why?
|
Up-Regulation | 5 | 2016 | 4217 | 0.160 |
Why?
|
Pyrimidinones | 1 | 2020 | 371 | 0.160 |
Why?
|
Immunotherapy | 3 | 2018 | 4445 | 0.160 |
Why?
|
Receptors, KIR | 6 | 1998 | 113 | 0.160 |
Why?
|
Alphapapillomavirus | 1 | 2021 | 221 | 0.160 |
Why?
|
Interleukin-4 | 3 | 2000 | 1147 | 0.160 |
Why?
|
Hematopoietic Cell Growth Factors | 2 | 1994 | 102 | 0.160 |
Why?
|
Microscopy, Fluorescence | 5 | 2008 | 2699 | 0.160 |
Why?
|
Carboplatin | 2 | 2018 | 801 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2021 | 5221 | 0.150 |
Why?
|
Mouth Mucosa | 2 | 2019 | 434 | 0.150 |
Why?
|
Cells | 1 | 1999 | 168 | 0.150 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3586 | 0.150 |
Why?
|
DNA Primers | 5 | 2008 | 2892 | 0.150 |
Why?
|
RNA Helicases | 1 | 2018 | 142 | 0.150 |
Why?
|
Chromosome Aberrations | 6 | 2018 | 1813 | 0.150 |
Why?
|
Kinetics | 9 | 2016 | 6473 | 0.150 |
Why?
|
Janus Kinase 2 | 8 | 2005 | 528 | 0.150 |
Why?
|
Receptors, Cytokine | 2 | 1996 | 261 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 2 | 2000 | 805 | 0.150 |
Why?
|
Isoenzymes | 1 | 2001 | 1726 | 0.140 |
Why?
|
Platinum | 4 | 2020 | 233 | 0.140 |
Why?
|
Models, Chemical | 1 | 1999 | 626 | 0.140 |
Why?
|
Lymphocyte Activation | 6 | 2000 | 5524 | 0.140 |
Why?
|
Ligases | 1 | 1998 | 333 | 0.140 |
Why?
|
Acetaldehyde | 1 | 2016 | 39 | 0.140 |
Why?
|
Interferon-gamma | 7 | 2000 | 3206 | 0.140 |
Why?
|
Cysteine Endopeptidases | 2 | 2001 | 563 | 0.140 |
Why?
|
INDEL Mutation | 1 | 2017 | 279 | 0.140 |
Why?
|
Organ Culture Techniques | 1 | 2018 | 813 | 0.140 |
Why?
|
Sister Chromatid Exchange | 3 | 2006 | 60 | 0.140 |
Why?
|
Reactive Oxygen Species | 3 | 2010 | 2077 | 0.140 |
Why?
|
Protein Folding | 2 | 2017 | 843 | 0.140 |
Why?
|
Embryonic Stem Cells | 3 | 2013 | 1294 | 0.140 |
Why?
|
Quinazolines | 1 | 2022 | 1356 | 0.140 |
Why?
|
Frameshift Mutation | 3 | 2006 | 399 | 0.130 |
Why?
|
Cytoplasm | 3 | 2001 | 1539 | 0.130 |
Why?
|
Macromolecular Substances | 5 | 2004 | 1454 | 0.130 |
Why?
|
Gene Expression | 14 | 2018 | 7799 | 0.130 |
Why?
|
Thiazoles | 2 | 2022 | 1483 | 0.130 |
Why?
|
Neoplasm Invasiveness | 3 | 2018 | 3616 | 0.130 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 407 | 0.130 |
Why?
|
Saccharomyces cerevisiae | 1 | 2006 | 2752 | 0.130 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2013 | 730 | 0.130 |
Why?
|
Transcription, Genetic | 4 | 2016 | 7722 | 0.130 |
Why?
|
DNA Mismatch Repair | 1 | 2018 | 426 | 0.130 |
Why?
|
DNA Polymerase II | 1 | 2015 | 107 | 0.130 |
Why?
|
Metformin | 1 | 2022 | 835 | 0.130 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 1997 | 315 | 0.130 |
Why?
|
Plasmids | 6 | 2006 | 2307 | 0.130 |
Why?
|
Methylation | 1 | 2017 | 1106 | 0.120 |
Why?
|
Protein Conformation | 8 | 2021 | 4011 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 9 | 2019 | 10943 | 0.120 |
Why?
|
Cyclin D1 | 1 | 2016 | 463 | 0.120 |
Why?
|
Sumoylation | 1 | 2015 | 83 | 0.120 |
Why?
|
Urinary Bladder Neoplasms | 2 | 2018 | 2245 | 0.120 |
Why?
|
Protein Stability | 2 | 2016 | 557 | 0.120 |
Why?
|
Boronic Acids | 3 | 2013 | 965 | 0.120 |
Why?
|
Deoxyribonucleases | 2 | 2018 | 214 | 0.120 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2013 | 47 | 0.120 |
Why?
|
Protein Subunits | 3 | 2013 | 959 | 0.120 |
Why?
|
Lymphoma, Mantle-Cell | 1 | 2016 | 233 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2023 | 1513 | 0.120 |
Why?
|
Genes, p53 | 1 | 1996 | 755 | 0.120 |
Why?
|
DNA, Single-Stranded | 3 | 2023 | 354 | 0.120 |
Why?
|
Thrombopoietin | 1 | 1996 | 225 | 0.120 |
Why?
|
Radiotherapy | 3 | 2016 | 1533 | 0.120 |
Why?
|
Molecular Targeted Therapy | 2 | 2015 | 2727 | 0.120 |
Why?
|
Male | 37 | 2023 | 350118 | 0.120 |
Why?
|
Salvage Therapy | 1 | 2020 | 1275 | 0.110 |
Why?
|
Radiation-Sensitizing Agents | 2 | 2013 | 358 | 0.110 |
Why?
|
Pedigree | 4 | 2015 | 4644 | 0.110 |
Why?
|
Histocompatibility Antigens Class I | 2 | 1998 | 1366 | 0.110 |
Why?
|
Immunologic Memory | 1 | 2000 | 1348 | 0.110 |
Why?
|
Cell Differentiation | 8 | 1997 | 11483 | 0.110 |
Why?
|
DNA Methylation | 6 | 2019 | 4286 | 0.110 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2016 | 671 | 0.110 |
Why?
|
Cyclin E | 1 | 2013 | 172 | 0.110 |
Why?
|
Neoplasms, Squamous Cell | 1 | 2013 | 96 | 0.110 |
Why?
|
Genetic Testing | 2 | 2023 | 3444 | 0.110 |
Why?
|
Gene Transfer Techniques | 1 | 1998 | 1224 | 0.110 |
Why?
|
Coumarins | 2 | 2016 | 119 | 0.110 |
Why?
|
Granulocytes | 3 | 2005 | 548 | 0.110 |
Why?
|
Interleukin-13 | 1 | 1995 | 389 | 0.110 |
Why?
|
Mutagenesis, Site-Directed | 3 | 2019 | 1723 | 0.110 |
Why?
|
Polycythemia | 4 | 1994 | 126 | 0.110 |
Why?
|
Disease-Free Survival | 4 | 2016 | 6895 | 0.110 |
Why?
|
Antibodies, Monoclonal | 4 | 1994 | 9274 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 7 | 1996 | 4420 | 0.110 |
Why?
|
DNA Copy Number Variations | 1 | 2021 | 1941 | 0.110 |
Why?
|
Enzyme Activation | 8 | 2013 | 3701 | 0.110 |
Why?
|
Amino Acid Motifs | 1 | 2015 | 936 | 0.110 |
Why?
|
Receptors, KIR3DL1 | 3 | 1996 | 22 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1997 | 1821 | 0.100 |
Why?
|
Urothelium | 1 | 2014 | 277 | 0.100 |
Why?
|
Conserved Sequence | 3 | 2014 | 1202 | 0.100 |
Why?
|
Amino Acids, Dicarboxylic | 1 | 2011 | 25 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-cbl | 2 | 2006 | 119 | 0.100 |
Why?
|
Cyclopentanes | 1 | 2012 | 91 | 0.100 |
Why?
|
Stress, Physiological | 2 | 2017 | 1403 | 0.100 |
Why?
|
Glioma | 1 | 2007 | 3401 | 0.100 |
Why?
|
Infertility | 2 | 2013 | 655 | 0.100 |
Why?
|
Procollagen-Proline Dioxygenase | 1 | 2011 | 86 | 0.100 |
Why?
|
Disease Models, Animal | 8 | 2021 | 18029 | 0.100 |
Why?
|
Radiation-Protective Agents | 1 | 2011 | 90 | 0.100 |
Why?
|
Interleukin-10 | 2 | 1995 | 1200 | 0.100 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 365 | 0.100 |
Why?
|
Crosses, Genetic | 2 | 2009 | 791 | 0.100 |
Why?
|
Lectins, C-Type | 3 | 2000 | 588 | 0.100 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2011 | 65 | 0.100 |
Why?
|
Leukemia | 2 | 2013 | 1511 | 0.100 |
Why?
|
Mice, Inbred NOD | 3 | 2021 | 1878 | 0.100 |
Why?
|
Myelodysplastic Syndromes | 1 | 2021 | 1352 | 0.090 |
Why?
|
Receptors, Colony-Stimulating Factor | 1 | 1990 | 49 | 0.090 |
Why?
|
Adult | 20 | 2023 | 214055 | 0.090 |
Why?
|
Tandem Repeat Sequences | 1 | 2011 | 185 | 0.090 |
Why?
|
Replication Protein A | 1 | 2010 | 52 | 0.090 |
Why?
|
Child | 13 | 2022 | 77709 | 0.090 |
Why?
|
Genes, ras | 1 | 2013 | 690 | 0.090 |
Why?
|
Protein Interaction Domains and Motifs | 3 | 2019 | 474 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 318 | 0.090 |
Why?
|
Globins | 4 | 1995 | 415 | 0.090 |
Why?
|
Promoter Regions, Genetic | 4 | 2019 | 5867 | 0.090 |
Why?
|
Hematologic Diseases | 1 | 1994 | 498 | 0.090 |
Why?
|
Epoxy Compounds | 4 | 2003 | 136 | 0.090 |
Why?
|
Antigen-Presenting Cells | 1 | 1993 | 973 | 0.090 |
Why?
|
Escherichia coli Proteins | 1 | 1996 | 1050 | 0.090 |
Why?
|
Fluoroquinolones | 1 | 2011 | 310 | 0.090 |
Why?
|
Child, Preschool | 8 | 2020 | 41006 | 0.090 |
Why?
|
Isoxazoles | 2 | 2021 | 216 | 0.090 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 1990 | 367 | 0.090 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 362 | 0.090 |
Why?
|
Germ Cells | 1 | 2013 | 631 | 0.090 |
Why?
|
Oncogene Proteins | 1 | 2013 | 749 | 0.090 |
Why?
|
Tryptophan | 2 | 2014 | 478 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2021 | 1587 | 0.080 |
Why?
|
Sequence Homology, Nucleic Acid | 7 | 1993 | 1085 | 0.080 |
Why?
|
Prognosis | 6 | 2022 | 29063 | 0.080 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 6 | 2003 | 903 | 0.080 |
Why?
|
MicroRNAs | 2 | 2016 | 3752 | 0.080 |
Why?
|
Middle Aged | 21 | 2023 | 213383 | 0.080 |
Why?
|
DNA Mutational Analysis | 6 | 2020 | 4186 | 0.080 |
Why?
|
Fluorescent Antibody Technique | 3 | 2016 | 2505 | 0.080 |
Why?
|
Cell Fractionation | 2 | 2002 | 252 | 0.080 |
Why?
|
Herpesvirus 4, Human | 3 | 2002 | 1041 | 0.080 |
Why?
|
Aged, 80 and over | 9 | 2023 | 57776 | 0.080 |
Why?
|
Epistasis, Genetic | 1 | 2011 | 365 | 0.080 |
Why?
|
Lung Neoplasms | 3 | 2021 | 13102 | 0.080 |
Why?
|
Ubiquitin-Activating Enzymes | 1 | 2008 | 83 | 0.080 |
Why?
|
Two-Hybrid System Techniques | 3 | 2012 | 464 | 0.080 |
Why?
|
Genetic Heterogeneity | 2 | 2002 | 733 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-raf | 3 | 1997 | 203 | 0.080 |
Why?
|
Exons | 5 | 2018 | 2437 | 0.080 |
Why?
|
Structure-Activity Relationship | 5 | 2016 | 3129 | 0.080 |
Why?
|
Genetic Variation | 3 | 2016 | 6544 | 0.080 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1940 | 0.080 |
Why?
|
Camptothecin | 1 | 2011 | 576 | 0.080 |
Why?
|
STAT5 Transcription Factor | 5 | 2001 | 259 | 0.080 |
Why?
|
Aged | 15 | 2023 | 163280 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2011 | 627 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 1998 | 146 | 0.080 |
Why?
|
Immunoprecipitation | 2 | 2010 | 905 | 0.080 |
Why?
|
Carbazoles | 1 | 2009 | 226 | 0.080 |
Why?
|
Dacarbazine | 2 | 2009 | 566 | 0.070 |
Why?
|
Chromosome Mapping | 5 | 1997 | 4740 | 0.070 |
Why?
|
Oxidative Stress | 2 | 2010 | 3086 | 0.070 |
Why?
|
Carmustine | 1 | 2007 | 137 | 0.070 |
Why?
|
Genetic Vectors | 3 | 2002 | 3420 | 0.070 |
Why?
|
Genome, Human | 2 | 2019 | 4420 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4751 | 0.070 |
Why?
|
Green Fluorescent Proteins | 2 | 2010 | 2088 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2023 | 4479 | 0.070 |
Why?
|
Androstadienes | 2 | 2006 | 346 | 0.070 |
Why?
|
Retroviridae Infections | 2 | 2000 | 151 | 0.070 |
Why?
|
Blood Proteins | 1 | 2011 | 1124 | 0.070 |
Why?
|
Molecular Weight | 6 | 1994 | 2255 | 0.070 |
Why?
|
Homeostasis | 2 | 2008 | 3340 | 0.070 |
Why?
|
SUMO-1 Protein | 1 | 2006 | 35 | 0.070 |
Why?
|
Protein Isoforms | 3 | 2016 | 1730 | 0.070 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1997 | 110 | 0.070 |
Why?
|
Organ Specificity | 2 | 2010 | 2008 | 0.070 |
Why?
|
Nijmegen Breakage Syndrome | 1 | 2005 | 5 | 0.070 |
Why?
|
RNA Splicing | 2 | 2004 | 907 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1353 | 0.070 |
Why?
|
DNA Modification Methylases | 1 | 2007 | 206 | 0.070 |
Why?
|
Sequence Alignment | 4 | 2009 | 2256 | 0.070 |
Why?
|
Precipitin Tests | 4 | 2002 | 829 | 0.070 |
Why?
|
Binding, Competitive | 2 | 2000 | 1157 | 0.070 |
Why?
|
Time Factors | 7 | 2014 | 40075 | 0.070 |
Why?
|
Genotype | 5 | 2022 | 12951 | 0.070 |
Why?
|
Genes | 4 | 1990 | 1893 | 0.070 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 503 | 0.070 |
Why?
|
Threonine | 1 | 2006 | 279 | 0.070 |
Why?
|
Epitopes | 3 | 2001 | 2571 | 0.070 |
Why?
|
Treatment Outcome | 8 | 2020 | 63114 | 0.070 |
Why?
|
Zebrafish | 3 | 2021 | 2994 | 0.070 |
Why?
|
Clone Cells | 5 | 1996 | 1692 | 0.070 |
Why?
|
Carcinoma, Basal Cell | 1 | 2011 | 545 | 0.070 |
Why?
|
Embryo, Nonmammalian | 1 | 2009 | 895 | 0.070 |
Why?
|
Guanine | 1 | 2007 | 274 | 0.070 |
Why?
|
Alkylating Agents | 1 | 2006 | 139 | 0.070 |
Why?
|
Ubiquitin-Conjugating Enzymes | 1 | 2006 | 195 | 0.070 |
Why?
|
Drosophila melanogaster | 2 | 2009 | 1708 | 0.070 |
Why?
|
Chromosome Fragile Sites | 1 | 2005 | 27 | 0.070 |
Why?
|
Antigens, CD | 4 | 2003 | 4026 | 0.070 |
Why?
|
Cytokines | 6 | 2011 | 7322 | 0.060 |
Why?
|
Cricetinae | 5 | 2009 | 2472 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 6 | 1998 | 3772 | 0.060 |
Why?
|
Mosaicism | 2 | 2006 | 441 | 0.060 |
Why?
|
Stromal Cells | 1 | 2010 | 1355 | 0.060 |
Why?
|
Mice, Mutant Strains | 3 | 2021 | 1866 | 0.060 |
Why?
|
Ovary | 3 | 2020 | 981 | 0.060 |
Why?
|
Cohort Studies | 8 | 2023 | 40561 | 0.060 |
Why?
|
Mutant Proteins | 1 | 2007 | 500 | 0.060 |
Why?
|
Diabetes Mellitus | 1 | 2003 | 5751 | 0.060 |
Why?
|
Indazoles | 2 | 2020 | 289 | 0.060 |
Why?
|
Bacterial Proteins | 2 | 2005 | 3848 | 0.060 |
Why?
|
Blotting, Northern | 2 | 1997 | 1581 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2018 | 809 | 0.060 |
Why?
|
Isoquinolines | 1 | 2006 | 367 | 0.060 |
Why?
|
Immune Sera | 2 | 1998 | 641 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2716 | 0.060 |
Why?
|
Radiation Injuries | 1 | 2011 | 1180 | 0.060 |
Why?
|
Thrombocythemia, Essential | 1 | 2005 | 105 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2020 | 39050 | 0.060 |
Why?
|
Survival Analysis | 4 | 2018 | 10252 | 0.060 |
Why?
|
Benzazepines | 1 | 2006 | 326 | 0.060 |
Why?
|
Drug Synergism | 3 | 2019 | 1792 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2012 | 15076 | 0.060 |
Why?
|
Culture Media, Conditioned | 2 | 2016 | 537 | 0.060 |
Why?
|
Glycoproteins | 1 | 1992 | 2263 | 0.060 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2006 | 443 | 0.060 |
Why?
|
Dipyridamole | 1 | 2003 | 145 | 0.060 |
Why?
|
Adolescent | 7 | 2020 | 85781 | 0.060 |
Why?
|
Dobutamine | 1 | 2003 | 123 | 0.060 |
Why?
|
Blotting, Southern | 4 | 2001 | 803 | 0.060 |
Why?
|
Interphase | 1 | 1983 | 226 | 0.060 |
Why?
|
Histone Chaperones | 1 | 2003 | 76 | 0.060 |
Why?
|
src Homology Domains | 3 | 2001 | 364 | 0.060 |
Why?
|
Polymerase Chain Reaction | 4 | 2016 | 6171 | 0.060 |
Why?
|
Primary Myelofibrosis | 1 | 2005 | 215 | 0.050 |
Why?
|
Skin Neoplasms | 2 | 2013 | 5686 | 0.050 |
Why?
|
Serine | 1 | 2006 | 826 | 0.050 |
Why?
|
Interferon-alpha | 2 | 1997 | 895 | 0.050 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2022 | 76 | 0.050 |
Why?
|
Trioxsalen | 1 | 2001 | 2 | 0.050 |
Why?
|
Phosphotyrosine | 3 | 2001 | 457 | 0.050 |
Why?
|
Gene Products, env | 3 | 1992 | 263 | 0.050 |
Why?
|
Microfilament Proteins | 1 | 2007 | 1152 | 0.050 |
Why?
|
Genes, cdc | 1 | 2002 | 116 | 0.050 |
Why?
|
Indoles | 2 | 2011 | 1839 | 0.050 |
Why?
|
CRADD Signaling Adaptor Protein | 1 | 2021 | 6 | 0.050 |
Why?
|
Phosphoserine | 1 | 2002 | 206 | 0.050 |
Why?
|
Adrenergic beta-Agonists | 1 | 2003 | 346 | 0.050 |
Why?
|
Oncogenes | 2 | 2021 | 1265 | 0.050 |
Why?
|
Glutathione S-Transferase pi | 1 | 2001 | 97 | 0.050 |
Why?
|
Spleen | 2 | 2001 | 2362 | 0.050 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2021 | 34 | 0.050 |
Why?
|
Anemia, Aplastic | 1 | 2003 | 226 | 0.050 |
Why?
|
Jurkat Cells | 2 | 2019 | 743 | 0.050 |
Why?
|
Mevalonic Acid | 1 | 2021 | 42 | 0.050 |
Why?
|
Tissue Distribution | 1 | 2006 | 2327 | 0.050 |
Why?
|
Brain Stem Neoplasms | 1 | 2003 | 204 | 0.050 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2005 | 547 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2003 | 336 | 0.050 |
Why?
|
Rabbits | 3 | 2001 | 4894 | 0.050 |
Why?
|
Spermatocytes | 1 | 2001 | 42 | 0.050 |
Why?
|
Tonsillar Neoplasms | 1 | 2001 | 51 | 0.050 |
Why?
|
Synaptonemal Complex | 1 | 2001 | 26 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 97 | 0.050 |
Why?
|
Systole | 1 | 2003 | 958 | 0.050 |
Why?
|
Protein Transport | 1 | 2007 | 1988 | 0.050 |
Why?
|
COS Cells | 2 | 2000 | 1161 | 0.050 |
Why?
|
Hybrid Cells | 3 | 2001 | 441 | 0.050 |
Why?
|
Anemia, Diamond-Blackfan | 1 | 2002 | 137 | 0.050 |
Why?
|
Wilms Tumor | 1 | 2003 | 373 | 0.050 |
Why?
|
U937 Cells | 1 | 2021 | 268 | 0.050 |
Why?
|
Amino Acid Substitution | 3 | 2002 | 1791 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 629 | 0.050 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2001 | 166 | 0.050 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2012 | 1736 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2000 | 80 | 0.050 |
Why?
|
Leukemia, Myeloid | 1 | 2003 | 707 | 0.050 |
Why?
|
Chromosomes, Human | 1 | 2002 | 457 | 0.050 |
Why?
|
Cell Membrane | 5 | 1994 | 3748 | 0.050 |
Why?
|
Genome | 1 | 2009 | 1808 | 0.050 |
Why?
|
Flow Cytometry | 5 | 2004 | 5974 | 0.050 |
Why?
|
DNA, Recombinant | 1 | 2000 | 476 | 0.040 |
Why?
|
L-Selectin | 1 | 2000 | 213 | 0.040 |
Why?
|
Genetic Counseling | 1 | 2023 | 600 | 0.040 |
Why?
|
Pyrimidines | 1 | 2012 | 2942 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7913 | 0.040 |
Why?
|
Ribosomal Proteins | 1 | 2002 | 360 | 0.040 |
Why?
|
Genes, Recessive | 2 | 2000 | 641 | 0.040 |
Why?
|
Mice, Inbred BALB C | 4 | 2011 | 6386 | 0.040 |
Why?
|
Siblings | 1 | 2003 | 854 | 0.040 |
Why?
|
K562 Cells | 1 | 2021 | 634 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2006 | 1613 | 0.040 |
Why?
|
Gene Library | 3 | 2014 | 1074 | 0.040 |
Why?
|
Consensus Sequence | 1 | 1999 | 377 | 0.040 |
Why?
|
Growth Substances | 1 | 2001 | 784 | 0.040 |
Why?
|
Radioimmunoassay | 2 | 1992 | 919 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2003 | 977 | 0.040 |
Why?
|
Catalytic Domain | 1 | 2001 | 698 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2375 | 0.040 |
Why?
|
Neoplasm, Residual | 1 | 2023 | 973 | 0.040 |
Why?
|
Meiosis | 1 | 2001 | 339 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2002 | 692 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2003 | 602 | 0.040 |
Why?
|
Antigens, Nuclear | 2 | 2012 | 192 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1997 | 494 | 0.040 |
Why?
|
HLA-DR Antigens | 1 | 2000 | 645 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.040 |
Why?
|
Medulloblastoma | 1 | 2003 | 683 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2020 | 3479 | 0.040 |
Why?
|
Janus Kinase 1 | 2 | 1996 | 104 | 0.040 |
Why?
|
Inflammation | 1 | 1998 | 10638 | 0.040 |
Why?
|
Response Elements | 1 | 1999 | 312 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2000 | 906 | 0.040 |
Why?
|
Antigens, Neoplasm | 2 | 2016 | 1988 | 0.040 |
Why?
|
Tumor Virus Infections | 1 | 2000 | 452 | 0.040 |
Why?
|
Haploinsufficiency | 1 | 2019 | 328 | 0.040 |
Why?
|
Membrane Glycoproteins | 3 | 1998 | 3768 | 0.040 |
Why?
|
Inhibitory Concentration 50 | 2 | 2013 | 459 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2019 | 4803 | 0.040 |
Why?
|
Neutropenia | 2 | 2011 | 895 | 0.040 |
Why?
|
Bone Marrow Transplantation | 1 | 1986 | 2765 | 0.040 |
Why?
|
Enzyme Assays | 1 | 2018 | 111 | 0.040 |
Why?
|
Chromosome Inversion | 1 | 1998 | 127 | 0.040 |
Why?
|
Shc Signaling Adaptor Proteins | 1 | 1997 | 46 | 0.040 |
Why?
|
Species Specificity | 2 | 1993 | 2478 | 0.040 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 1 | 1996 | 21 | 0.040 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
Observer Variation | 1 | 2003 | 2593 | 0.040 |
Why?
|
Indolizines | 1 | 2016 | 37 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 2 | 1998 | 1838 | 0.040 |
Why?
|
Neoplasm Metastasis | 2 | 2020 | 4851 | 0.040 |
Why?
|
GRB2 Adaptor Protein | 1 | 1997 | 103 | 0.040 |
Why?
|
Cyclic N-Oxides | 1 | 2016 | 78 | 0.040 |
Why?
|
CHO Cells | 2 | 2001 | 1406 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2010 | 3647 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2003 | 2373 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2006 | 1888 | 0.040 |
Why?
|
Pyridinium Compounds | 1 | 2016 | 84 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2016 | 6773 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2000 | 578 | 0.040 |
Why?
|
Maximum Tolerated Dose | 1 | 2019 | 892 | 0.040 |
Why?
|
Interleukin-5 | 1 | 1997 | 273 | 0.040 |
Why?
|
Sulfonamides | 1 | 2006 | 1938 | 0.030 |
Why?
|
Cricetulus | 3 | 2009 | 816 | 0.030 |
Why?
|
Superantigens | 1 | 1996 | 129 | 0.030 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.030 |
Why?
|
Stem Cell Factor | 1 | 1996 | 219 | 0.030 |
Why?
|
Antibody Specificity | 2 | 2001 | 1095 | 0.030 |
Why?
|
Neomycin | 1 | 1996 | 88 | 0.030 |
Why?
|
Abnormalities, Multiple | 1 | 2003 | 1416 | 0.030 |
Why?
|
Receptors, KIR2DL3 | 1 | 1995 | 17 | 0.030 |
Why?
|
Interleukin-15 | 1 | 1997 | 184 | 0.030 |
Why?
|
Receptors, KIR3DS1 | 1 | 1995 | 9 | 0.030 |
Why?
|
Receptors, Interleukin | 1 | 1997 | 245 | 0.030 |
Why?
|
Drug Combinations | 1 | 2021 | 1959 | 0.030 |
Why?
|
Biological Transport | 1 | 2000 | 2118 | 0.030 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2003 | 1873 | 0.030 |
Why?
|
Counseling | 1 | 2023 | 1523 | 0.030 |
Why?
|
Introns | 1 | 2018 | 991 | 0.030 |
Why?
|
Gene Amplification | 1 | 2020 | 1063 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3597 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2018 | 11124 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2016 | 11031 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1880 | 0.030 |
Why?
|
Young Adult | 4 | 2023 | 56430 | 0.030 |
Why?
|
Radiation | 1 | 2015 | 49 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 2017 | 458 | 0.030 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1994 | 821 | 0.030 |
Why?
|
Ligands | 3 | 1998 | 3282 | 0.030 |
Why?
|
Hydrolysis | 1 | 2016 | 682 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 1998 | 1827 | 0.030 |
Why?
|
Phosphates | 1 | 1998 | 786 | 0.030 |
Why?
|
Oligopeptides | 1 | 2000 | 1189 | 0.030 |
Why?
|
Allosteric Regulation | 1 | 2016 | 408 | 0.030 |
Why?
|
Zebrafish Proteins | 1 | 2021 | 1005 | 0.030 |
Why?
|
Cyanoacrylates | 1 | 2015 | 49 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2011 | 12245 | 0.030 |
Why?
|
Hemagglutinins, Viral | 1 | 1994 | 67 | 0.030 |
Why?
|
Enterotoxins | 1 | 1996 | 368 | 0.030 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2017 | 404 | 0.030 |
Why?
|
Chemokine CXCL12 | 1 | 2016 | 464 | 0.030 |
Why?
|
Codon | 1 | 1996 | 611 | 0.030 |
Why?
|
Reference Values | 1 | 2001 | 4982 | 0.030 |
Why?
|
Pimozide | 1 | 2013 | 21 | 0.030 |
Why?
|
Clonal Anergy | 1 | 1994 | 169 | 0.030 |
Why?
|
Survival Rate | 2 | 2020 | 12788 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2003 | 2289 | 0.030 |
Why?
|
Erythrocytes | 3 | 1994 | 2455 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 956 | 0.030 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2006 | 2214 | 0.030 |
Why?
|
Bone Neoplasms | 1 | 2006 | 2529 | 0.030 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 1801 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 1996 | 648 | 0.030 |
Why?
|
Fetal Blood | 1 | 2000 | 1318 | 0.030 |
Why?
|
Lentivirus | 1 | 2016 | 501 | 0.030 |
Why?
|
Muscles | 1 | 2018 | 1614 | 0.030 |
Why?
|
Antigen-Antibody Reactions | 1 | 1993 | 363 | 0.030 |
Why?
|
Substrate Specificity | 2 | 2016 | 1801 | 0.030 |
Why?
|
Graft vs Host Disease | 1 | 1986 | 2957 | 0.030 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8642 | 0.030 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1994 | 157 | 0.030 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1993 | 370 | 0.030 |
Why?
|
Benzoquinones | 1 | 2013 | 201 | 0.030 |
Why?
|
Dwarfism | 1 | 1994 | 146 | 0.030 |
Why?
|
Disease Management | 1 | 2003 | 2459 | 0.030 |
Why?
|
Melanoma | 1 | 2011 | 5510 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2003 | 2148 | 0.030 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2003 | 2073 | 0.030 |
Why?
|
Proto-Oncogenes | 1 | 1993 | 321 | 0.030 |
Why?
|
China | 1 | 2018 | 2248 | 0.030 |
Why?
|
Phenylalanine | 1 | 2014 | 365 | 0.030 |
Why?
|
HLA Antigens | 1 | 1998 | 1381 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.030 |
Why?
|
Macrophages | 2 | 2020 | 5655 | 0.030 |
Why?
|
Restriction Mapping | 2 | 1990 | 878 | 0.030 |
Why?
|
Methionine | 1 | 1994 | 590 | 0.030 |
Why?
|
Caffeine | 1 | 1996 | 699 | 0.030 |
Why?
|
Lactams, Macrocyclic | 1 | 2013 | 320 | 0.030 |
Why?
|
Platinum Compounds | 1 | 2012 | 96 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2014 | 684 | 0.030 |
Why?
|
Severe Combined Immunodeficiency | 1 | 1994 | 223 | 0.030 |
Why?
|
Piperidines | 1 | 2020 | 1602 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 1998 | 1782 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2012 | 0.020 |
Why?
|
Exosomes | 1 | 2016 | 417 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1998 | 2540 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2012 | 436 | 0.020 |
Why?
|
Muridae | 1 | 1990 | 61 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2012 | 563 | 0.020 |
Why?
|
Heart Ventricles | 1 | 2003 | 3821 | 0.020 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2011 | 113 | 0.020 |
Why?
|
Risk Factors | 3 | 2014 | 72290 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 2 | 2012 | 6538 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 2011 | 449 | 0.020 |
Why?
|
Cattle | 1 | 1997 | 3922 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2011 | 403 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2016 | 1117 | 0.020 |
Why?
|
Radiometry | 1 | 2016 | 800 | 0.020 |
Why?
|
Genes, env | 1 | 1990 | 95 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 767 | 0.020 |
Why?
|
Stroke Volume | 1 | 2003 | 5007 | 0.020 |
Why?
|
3T3 Cells | 2 | 2003 | 1101 | 0.020 |
Why?
|
Tyrosine | 2 | 1992 | 1461 | 0.020 |
Why?
|
Neoplasms, Experimental | 2 | 2011 | 1276 | 0.020 |
Why?
|
Liver Neoplasms | 1 | 2006 | 4253 | 0.020 |
Why?
|
Transformation, Bacterial | 1 | 2010 | 78 | 0.020 |
Why?
|
Endotoxemia | 1 | 2011 | 207 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2012 | 216 | 0.020 |
Why?
|
Gamma Rays | 2 | 2001 | 320 | 0.020 |
Why?
|
Electrocardiography | 1 | 2003 | 6442 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11366 | 0.020 |
Why?
|
Staphylococcus aureus | 2 | 1995 | 1451 | 0.020 |
Why?
|
Interleukin-1 | 1 | 1993 | 1263 | 0.020 |
Why?
|
Testis | 1 | 1993 | 803 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2009 | 32 | 0.020 |
Why?
|
Endoplasmic Reticulum | 2 | 1992 | 1144 | 0.020 |
Why?
|
Endotoxins | 1 | 2011 | 527 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2029 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1692 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2022 | 4386 | 0.020 |
Why?
|
Antigens, Surface | 1 | 1993 | 1663 | 0.020 |
Why?
|
Peptide Fragments | 2 | 2001 | 5097 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 1708 | 0.020 |
Why?
|
Ablation Techniques | 1 | 2011 | 249 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3638 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily D | 2 | 1998 | 29 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily C | 2 | 1998 | 32 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2021 | 9734 | 0.020 |
Why?
|
Receptors, Natural Killer Cell | 2 | 1998 | 57 | 0.020 |
Why?
|
Protein Denaturation | 2 | 2001 | 237 | 0.020 |
Why?
|
Neutralization Tests | 1 | 1990 | 758 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1654 | 0.020 |
Why?
|
Strongylocentrotus purpuratus | 1 | 2007 | 5 | 0.020 |
Why?
|
Infant | 4 | 2018 | 35136 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 2011 | 0.020 |
Why?
|
Forecasting | 1 | 1996 | 2951 | 0.020 |
Why?
|
Immunosorbent Techniques | 2 | 2001 | 184 | 0.020 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1991 | 794 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2085 | 0.020 |
Why?
|
Autoantigens | 1 | 2011 | 892 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1915 | 0.020 |
Why?
|
Monocytes | 2 | 1994 | 2596 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2003 | 4262 | 0.020 |
Why?
|
Organ Size | 1 | 2011 | 2252 | 0.020 |
Why?
|
Endocytosis | 1 | 1991 | 985 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 720 | 0.020 |
Why?
|
Bromodeoxyuridine | 2 | 1984 | 322 | 0.020 |
Why?
|
Receptors, Progesterone | 1 | 2010 | 1097 | 0.020 |
Why?
|
Benzimidazoles | 1 | 2011 | 850 | 0.020 |
Why?
|
Elbow | 1 | 2006 | 138 | 0.020 |
Why?
|
Family Health | 2 | 2005 | 1282 | 0.020 |
Why?
|
Aphidicolin | 1 | 2005 | 36 | 0.020 |
Why?
|
Pancytopenia | 1 | 2006 | 104 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5720 | 0.020 |
Why?
|
Genetic Linkage | 1 | 1990 | 2421 | 0.020 |
Why?
|
Incidence | 1 | 2003 | 20947 | 0.020 |
Why?
|
Risk Assessment | 1 | 2006 | 23338 | 0.020 |
Why?
|
NF-kappa B | 1 | 2013 | 2499 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 9438 | 0.010 |
Why?
|
Genetic Markers | 1 | 1990 | 2634 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2005 | 876 | 0.010 |
Why?
|
Bisbenzimidazole | 1 | 1983 | 13 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 2006 | 456 | 0.010 |
Why?
|
Hydroxyurea | 1 | 2005 | 290 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2728 | 0.010 |
Why?
|
Multiple Endocrine Neoplasia Type 1 | 1 | 2003 | 46 | 0.010 |
Why?
|
Protein Structure, Secondary | 1 | 2006 | 1246 | 0.010 |
Why?
|
Viral Proteins | 1 | 1991 | 1900 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 1996 | 4665 | 0.010 |
Why?
|
Pyridines | 1 | 2015 | 2825 | 0.010 |
Why?
|
Chronic Disease | 1 | 1998 | 9146 | 0.010 |
Why?
|
Luminescent Proteins | 1 | 2005 | 853 | 0.010 |
Why?
|
Inflammation Mediators | 1 | 2011 | 1889 | 0.010 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2187 | 0.010 |
Why?
|
Subcellular Fractions | 1 | 2003 | 547 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 2 | 1998 | 1369 | 0.010 |
Why?
|
Lysine | 1 | 2007 | 1007 | 0.010 |
Why?
|
DNA, Ribosomal | 1 | 1983 | 290 | 0.010 |
Why?
|
Bone Diseases | 1 | 2006 | 416 | 0.010 |
Why?
|
Mechlorethamine | 1 | 2001 | 136 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3760 | 0.010 |
Why?
|
Leupeptins | 1 | 2001 | 122 | 0.010 |
Why?
|
Nucleic Acid Hybridization | 1 | 1983 | 1375 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2000 | 25625 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2003 | 433 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2006 | 1850 | 0.010 |
Why?
|
Karyotyping | 1 | 2003 | 1243 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2009 | 1678 | 0.010 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2001 | 140 | 0.010 |
Why?
|
Erythroid-Specific DNA-Binding Factors | 2 | 1991 | 198 | 0.010 |
Why?
|
Neuroblastoma | 1 | 1989 | 1226 | 0.010 |
Why?
|
Receptor, erbB-2 | 1 | 2010 | 2416 | 0.010 |
Why?
|
Polymorphism, Single-Stranded Conformational | 1 | 2000 | 335 | 0.010 |
Why?
|
Bleomycin | 1 | 2001 | 512 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 2011 | 3036 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2006 | 12959 | 0.010 |
Why?
|
Cell Fusion | 1 | 2000 | 297 | 0.010 |
Why?
|
DNA Restriction Enzymes | 1 | 1980 | 570 | 0.010 |
Why?
|
Drosophila Proteins | 2 | 2001 | 1703 | 0.010 |
Why?
|
Membrane Proteins | 1 | 1996 | 7880 | 0.010 |
Why?
|
G-Quadruplexes | 1 | 2001 | 162 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2011 | 5442 | 0.010 |
Why?
|
Genes, abl | 1 | 1998 | 72 | 0.010 |
Why?
|
Recurrence | 1 | 2010 | 8340 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3251 | 0.010 |
Why?
|
Sheep | 1 | 2001 | 1437 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 1996 | 15540 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2005 | 1257 | 0.010 |
Why?
|
Receptors, Interleukin-5 | 1 | 1997 | 19 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2001 | 913 | 0.010 |
Why?
|
HLA-C Antigens | 1 | 1997 | 147 | 0.010 |
Why?
|
Kidney | 2 | 2010 | 7186 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12354 | 0.010 |
Why?
|
Lung | 1 | 2016 | 9856 | 0.010 |
Why?
|
HLA-A Antigens | 1 | 1997 | 231 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1998 | 315 | 0.010 |
Why?
|
Protein Sorting Signals | 1 | 1998 | 281 | 0.010 |
Why?
|
Interferon-Stimulated Gene Factor 3 | 1 | 1996 | 10 | 0.010 |
Why?
|
Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 1996 | 9 | 0.010 |
Why?
|
Calcium | 1 | 1990 | 5756 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 1997 | 425 | 0.010 |
Why?
|
STAT2 Transcription Factor | 1 | 1996 | 27 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1996 | 326 | 0.010 |
Why?
|
Adenovirus E1A Proteins | 1 | 1996 | 76 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 1997 | 196 | 0.010 |
Why?
|
Spodoptera | 1 | 1996 | 153 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 1434 | 0.010 |
Why?
|
CREB-Binding Protein | 1 | 1996 | 151 | 0.010 |
Why?
|
Esophageal Neoplasms | 1 | 2006 | 1583 | 0.010 |
Why?
|
Lymphoma | 1 | 2005 | 1877 | 0.010 |
Why?
|
Janus Kinases | 1 | 1997 | 244 | 0.010 |
Why?
|
Adenosine Triphosphate | 2 | 1992 | 2025 | 0.010 |
Why?
|
Mice, Inbred DBA | 1 | 1996 | 642 | 0.010 |
Why?
|
Blood Donors | 1 | 1997 | 355 | 0.010 |
Why?
|
Receptors, Thrombopoietin | 1 | 1996 | 157 | 0.010 |
Why?
|
HLA-DR7 Antigen | 1 | 1994 | 27 | 0.010 |
Why?
|
Lectins | 1 | 1997 | 513 | 0.010 |
Why?
|
Melanins | 1 | 1997 | 289 | 0.010 |
Why?
|
Solubility | 1 | 1996 | 1085 | 0.010 |
Why?
|
MAP Kinase Kinase 1 | 1 | 1996 | 337 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 2001 | 2242 | 0.010 |
Why?
|
Janus Kinase 3 | 1 | 1994 | 78 | 0.010 |
Why?
|
Guanidine | 1 | 1994 | 33 | 0.010 |
Why?
|
Disease Progression | 1 | 2011 | 13284 | 0.010 |
Why?
|
Myelin P2 Protein | 1 | 1993 | 20 | 0.010 |
Why?
|
Retroviridae Proteins, Oncogenic | 1 | 1993 | 76 | 0.010 |
Why?
|
Guanidines | 1 | 1994 | 193 | 0.010 |
Why?
|
Aging | 1 | 2012 | 8664 | 0.010 |
Why?
|
Chromatography, Affinity | 1 | 1994 | 549 | 0.010 |
Why?
|
Acute Disease | 1 | 2003 | 7149 | 0.010 |
Why?
|
Diphosphoglyceric Acids | 1 | 1992 | 32 | 0.010 |
Why?
|
2,3-Diphosphoglycerate | 1 | 1992 | 15 | 0.010 |
Why?
|
Bloodletting | 1 | 1992 | 23 | 0.010 |
Why?
|
Megakaryocytes | 1 | 1996 | 545 | 0.010 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 1992 | 279 | 0.010 |
Why?
|
Adenoviridae | 1 | 1996 | 1099 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2003 | 3617 | 0.010 |
Why?
|
Skin | 1 | 2006 | 4364 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1989 | 4584 | 0.010 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 1993 | 417 | 0.010 |
Why?
|
Fluorouracil | 1 | 1996 | 1619 | 0.010 |
Why?
|
Urea | 1 | 1994 | 450 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15519 | 0.010 |
Why?
|
Hypersensitivity | 1 | 2000 | 1102 | 0.010 |
Why?
|
Glutamic Acid | 1 | 1997 | 1169 | 0.010 |
Why?
|
Protein Multimerization | 1 | 1996 | 970 | 0.010 |
Why?
|
Enzyme Induction | 1 | 1991 | 475 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 342 | 0.010 |
Why?
|
Receptors, IgG | 1 | 1994 | 582 | 0.010 |
Why?
|
Endopeptidase K | 1 | 1990 | 23 | 0.010 |
Why?
|
Models, Statistical | 1 | 2005 | 5102 | 0.010 |
Why?
|
GATA1 Transcription Factor | 1 | 1991 | 293 | 0.010 |
Why?
|
Hexosaminidases | 1 | 1990 | 54 | 0.010 |
Why?
|
Liver | 1 | 2006 | 7474 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 427 | 0.010 |
Why?
|
Erythroblasts | 1 | 1990 | 150 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 1993 | 731 | 0.010 |
Why?
|
Cell Compartmentation | 1 | 1990 | 402 | 0.010 |
Why?
|
DNA Probes | 1 | 1990 | 560 | 0.010 |
Why?
|
Escherichia coli | 2 | 1998 | 4217 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1993 | 1950 | 0.010 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1991 | 648 | 0.010 |
Why?
|
Virus Replication | 1 | 1996 | 2534 | 0.010 |
Why?
|
Cell Lineage | 1 | 1996 | 2504 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 2001 | 4149 | 0.000 |
Why?
|
HIV Infections | 1 | 1994 | 16718 | 0.000 |
Why?
|
Interleukin-6 | 1 | 1996 | 3200 | 0.000 |
Why?
|
Neural Crest | 1 | 1989 | 275 | 0.000 |
Why?
|
Mediastinal Neoplasms | 1 | 1989 | 423 | 0.000 |
Why?
|
Lipopolysaccharides | 1 | 1993 | 2216 | 0.000 |
Why?
|
Retroperitoneal Neoplasms | 1 | 1989 | 340 | 0.000 |
Why?
|
Serine Endopeptidases | 1 | 1990 | 1072 | 0.000 |
Why?
|
Mitomycins | 1 | 1984 | 47 | 0.000 |
Why?
|
Pregnancy | 1 | 2006 | 29144 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 20129 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2010 | 77449 | 0.000 |
Why?
|
Chromosomes | 1 | 1984 | 596 | 0.000 |
Why?
|
Polynucleotide 5'-Hydroxyl-Kinase | 1 | 1980 | 8 | 0.000 |
Why?
|
T-Phages | 1 | 1980 | 90 | 0.000 |
Why?
|
Methods | 1 | 1980 | 1129 | 0.000 |
Why?
|
Rats | 1 | 1995 | 24260 | 0.000 |
Why?
|
Cell Movement | 1 | 1989 | 5217 | 0.000 |
Why?
|
Alkaline Phosphatase | 1 | 1980 | 865 | 0.000 |
Why?
|